Mid-Year Update on Follicular Lymphoma Pathways for Clinical and Translational Investigations
We are pleased to announce the publication of our latest update, “Follicular Lymphoma: Mid-year Update on Pathways for Clinical and Translational Investigations.
Blood Cancer Awareness Month – you can make a difference
Every 3 minutes, someone in the U.S. is diagnosed with blood cancer. Blood Cancer Awareness Month highlights leukemia, lymphoma, and myeloma.
Anne and Stewart’s fundraising story
Anne and Stewart recently completed an incredible 432-mile cycling journey in Scotland, raising over £2000 for the FLF.
Webinar: Understanding Follicular Lymphoma Clinical Trials
View our webinar focused on sharing experiences and improving understanding of clinical trials.
Tadmarton Heath’s fundraising story
Huge thanks to Tadmarton Heath Golf Club for hosting a charity event that raised over £6,000 for the FLF!
$2.25 Million to Research United to CURE Follicular Lymphoma
This strategic alliance with LLS and IFLI will further accelerate pioneering research and help cure follicular lymphoma through our Research United to CURE FL program.
Latest follicular lymphoma research updates from recent scientific conferences
The team updates from recent scientific conferences on the latest research in follicular lymphoma, from cutting-edge therapies to genetic insights.
Mark’s fundraising story
Mark is going on an incredible 540 mile walk across the Pyrenees from the Atlantic to the Mediterranean.
South West Coast 50 Ultra Challenge
Challenge yourself with the South West Coast 50 Ultra Challenge on Saturday 3rd August.
What is the potential for minimal residual disease in follicular lymphoma treatment?
Minimal/measurable residual disease refers to the small number of cancer cells remaining in the body after treatment.